Innova and TGR Enter Co-Marketing Agreement for Complementary Core Biotechnologies
|
By LabMedica International staff writers Posted on 02 Feb 2014 |
Combining ELISA technology from TGR BioSciences (Adelaide, Australia) with conjugation kits from Innova Biosciences (Cambridge, UK) improves ELISA sensitivity and reduces cost.
TGR develops rapid, high sensitivity ELISA systems using their CaptSure technology, and Innova provides superior bioconjugation systems. Having entered into the agreement to promote and co-market their highly complementary technologies, they can now provide customers with a major step forward in simplifying a laboratory's ELISA development process, while improving sensitivity and reducing costs.
TGR has determined that combining Innova’s "Lightning-Link" conjugation kits for the horseradish peroxidase (HRP) labeling of antibodies with its "CaptSure" technology enables rapid and cost-effective development of a wide range of high sensitivity ELISA assays. As part of the agreement, Innova customers will be introduced to the CaptSure technology as providing added value when used alongside Lightning-Link reagents. Similarly, Lightning-Link will be introduced to TGR customers with a recommendation of the added value when used alongside CaptSure products.
TGR’s CaptSure technology simplifies ELISA assays to one-step procedures, making them much faster and easier to carry out. Both assay antibodies are added to analyte at once, and after a single wash step, the HRP substrate is added to develop the signal. Importantly, manufacture and environmental costs are greatly reduced, since only a single assay plate is required (coated with CaptSure reagent) rather than a different plate for each target and the system requires much lower amounts of assay antibodies. Innova’s Lightning-Link conjugation system provides the ability to label antibodies with only 30 seconds hands-on time, while offering 100% yields and enhanced sensitivity over traditional labeling techniques and over other conjugation systems on the market.
“We’ve been impressed with Innova’s products. Their HRP conjugation kit is simple to use and at the same time provides performance that exceeds that of a range of other systems that we have tested. We are very happy to recommend Lightning-Link to anyone who is developing assays with our CaptSure system,” said Dr. Michael Crouch, Director of Business Development at TGR. Dr. Andy Lane, Executive Director at Innova Biosciences, said, "We are pleased to further develop our relationship with TGR. Their CaptSure technology provides advantages in ELISA assay development that are directly complementary to the ethos of our conjugation technology—simplicity, high speed, and enhanced sensitivity.”
Related Links:
TGR BioSciences
Innova Biosciences
TGR develops rapid, high sensitivity ELISA systems using their CaptSure technology, and Innova provides superior bioconjugation systems. Having entered into the agreement to promote and co-market their highly complementary technologies, they can now provide customers with a major step forward in simplifying a laboratory's ELISA development process, while improving sensitivity and reducing costs.
TGR has determined that combining Innova’s "Lightning-Link" conjugation kits for the horseradish peroxidase (HRP) labeling of antibodies with its "CaptSure" technology enables rapid and cost-effective development of a wide range of high sensitivity ELISA assays. As part of the agreement, Innova customers will be introduced to the CaptSure technology as providing added value when used alongside Lightning-Link reagents. Similarly, Lightning-Link will be introduced to TGR customers with a recommendation of the added value when used alongside CaptSure products.
TGR’s CaptSure technology simplifies ELISA assays to one-step procedures, making them much faster and easier to carry out. Both assay antibodies are added to analyte at once, and after a single wash step, the HRP substrate is added to develop the signal. Importantly, manufacture and environmental costs are greatly reduced, since only a single assay plate is required (coated with CaptSure reagent) rather than a different plate for each target and the system requires much lower amounts of assay antibodies. Innova’s Lightning-Link conjugation system provides the ability to label antibodies with only 30 seconds hands-on time, while offering 100% yields and enhanced sensitivity over traditional labeling techniques and over other conjugation systems on the market.
“We’ve been impressed with Innova’s products. Their HRP conjugation kit is simple to use and at the same time provides performance that exceeds that of a range of other systems that we have tested. We are very happy to recommend Lightning-Link to anyone who is developing assays with our CaptSure system,” said Dr. Michael Crouch, Director of Business Development at TGR. Dr. Andy Lane, Executive Director at Innova Biosciences, said, "We are pleased to further develop our relationship with TGR. Their CaptSure technology provides advantages in ELISA assay development that are directly complementary to the ethos of our conjugation technology—simplicity, high speed, and enhanced sensitivity.”
Related Links:
TGR BioSciences
Innova Biosciences
Latest Industry News
- Co-Diagnostics Forms New Business Unit to Develop AI-Powered Diagnostics
- Qiagen Acquires Single-Cell Omics Firm Parse Biosciences
- Puritan Medical Products Showcasing Innovation at AMP2025 in Boston
- Advanced Instruments Merged Under Nova Biomedical Name
- Bio-Rad and Biodesix Partner to Develop Droplet Digital PCR High Complexity Assays
- Hologic to be Acquired by Blackstone and TPG
- Bio-Techne and Oxford Nanopore to Accelerate Development of Genetics Portfolio
- Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders
- Revvity and Sanofi Collaborate on Program to Revolutionize Early Detection of Type 1 Diabetes
- GSI Group Acquires Blood Processing Equipment Manufacturer GenesisBPS
- ELITech and Hitachi High-Tech to Develop Automated PCR Testing System for Infectious Diseases
- Lumiquick Acquires Aoxre to Expand Global IVD and Research Capabilities
- Lunit and Agilent Partner to Develop AI-Powered Cancer Diagnostics
- Qiagen and Oxford Gene Technology Partner on Sequencing Panel Interpretation
- VedaBio Partners With Mammoth Biosciences to Expand CRISPR-Based Diagnostic Technologies
- Werfen and VolitionRx Partner to Advance Diagnostic Testing for Antiphospholipid Syndrome
Channels
Clinical Chemistry
view channel
VOCs Show Promise for Early Multi-Cancer Detection
Early cancer detection is critical to improving survival rates, but most current screening methods focus on individual cancer types and often involve invasive procedures. This makes it difficult to identify... Read more
Portable Raman Spectroscopy Offers Cost-Effective Kidney Disease Diagnosis at POC
Kidney disease is typically diagnosed through blood or urine tests, often when patients present with symptoms such as blood in urine, shortness of breath, or weight loss. While these tests are common,... Read moreMolecular Diagnostics
view channel
New Biomarker Panel to Improve Heart Failure Diagnosis in Women
Heart failure affects millions worldwide, yet many women are still misdiagnosed or diagnosed too late. Although heart failure broadly means the heart cannot pump enough blood to the body’s cells, its two... Read more
Dual Blood Biomarkers Improve ALS Diagnostic Accuracy
Diagnosing amyotrophic lateral sclerosis (ALS) remains difficult even with advanced imaging and genetic tools, especially when clinicians must distinguish it from other neurodegenerative conditions that... Read moreHematology
view channel
ADLM’s New Coagulation Testing Guidance to Improve Care for Patients on Blood Thinners
Direct oral anticoagulants (DOACs) are one of the most common types of blood thinners. Patients take them to prevent a host of complications that could arise from blood clotting, including stroke, deep... Read more
Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage
Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more
Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments
Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read moreImmunology
view channel
Chip Captures Cancer Cells from Blood to Help Select Right Breast Cancer Treatment
Ductal carcinoma in situ (DCIS) accounts for about a quarter of all breast cancer cases and generally carries a good prognosis. This non-invasive form of the disease may or may not become life-threatening.... Read more
Blood-Based Liquid Biopsy Model Analyzes Immunotherapy Effectiveness
Immunotherapy has revolutionized cancer care by harnessing the immune system to fight tumors, yet predicting who will benefit remains a major challenge. Many patients undergo costly and taxing treatment... Read moreMicrobiology
view channel
15-Minute Blood Test Diagnoses Life-Threatening Infections in Children
Distinguishing minor childhood illnesses from potentially life-threatening infections such as sepsis or meningitis remains a major challenge in emergency care. Traditional tests can take hours, leaving... Read more
High-Throughput Enteric Panels Detect Multiple GI Bacterial Infections from Single Stool Swab Sample
Gastrointestinal (GI) infections are among the most common causes of illness worldwide, leading to over 1.7 million deaths annually and placing a heavy burden on healthcare systems. Conventional diagnostic... Read morePathology
view channel
AI Tool Improves Accuracy of Skin Cancer Detection
Diagnosing melanoma accurately in people with darker skin remains a longstanding challenge. Many existing artificial intelligence (AI) tools detect skin cancer more reliably in lighter skin tones, often... Read more
Highly Sensitive Imaging Technique Detects Myelin Damage
Damage to myelin—the insulating layer that helps brain cells function efficiently—is a hallmark of many neurodegenerative diseases, age-related decline, and traumatic injuries. However, studying this damage... Read moreTechnology
view channel
AI Model Achieves Breakthrough Accuracy in Ovarian Cancer Detection
Early diagnosis of ovarian cancer remains one of the toughest challenges in women’s health. Traditional tools such as the Risk of Ovarian Malignancy Algorithm (ROMA) can struggle to distinguish between... Read more
Portable Biosensor Diagnoses Psychiatric Disorders Using Saliva Samples
Early diagnosis of psychiatric disorders such as depression, schizophrenia, and bipolar disorder remains one of medicine’s most pressing challenges. Current diagnostic methods rely heavily on clinical... Read more








